Diversity Council Business Blog

Business

Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine

Clinical dosimetry results from Phase 1 studies of Radspherin® in ovarian and colorectal cancer demonstrate absorbed doses to normal organs well below values associated with toxicity risks The results are consistent with the favorable safety profile observed to…

Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine Read More »

The 16th Worldwide Chinese Life Insurance Congress & 2026 International Dragon Award (IDA) Annual Conference Grandly Held

Over 10,000 financial insurance elites from around the world gathered in Hong KongHONG KONG, Aug. 8, 2026 /PRNewswire/ — From August 7 to 10, 2026, the 16th Worldwide Chinese Life Insurance Congress and the 2026 International Dragon Award…

The 16th Worldwide Chinese Life Insurance Congress & 2026 International Dragon Award (IDA) Annual Conference Grandly Held Read More »

A Manufacturer's Guide to Transdermal Patches

A Manufacturer’s Guide to Transdermal Patches

Understanding the Transdermal Patch A transdermal patch is a medicated adhesive system designed to deliver pharmaceutical ingredients through the skin over a predetermined period. Unlike oral medications that travel through the digestive tract, these patches provide controlled release directly into systemic circulation. The technology offers several advantages, including: These benefits have made the transdermal patch

A Manufacturer’s Guide to Transdermal Patches Read More »

Tetragon Financial Group Limited Announcement of Tender Offer to Purchase $50,000,000 of Tetragon Non-Voting Shares

LONDON, Aug. 6, 2026 /PRNewswire/ — Tetragon today announces the commencement of a tender offer to purchase a portion of its outstanding non-voting shares for a maximum aggregate payment of $50,000,000 in cash. The tender offer, which was…

Tetragon Financial Group Limited Announcement of Tender Offer to Purchase $50,000,000 of Tetragon Non-Voting Shares Read More »